| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA891818 | F | Antiviral activity against HAV in Vero cells assessed as plaque infectivity reduction at 10 ug/ml | Hepatovirus A | 10 | ALA1147850 | organism-based format | Scientific Literature | |
| 2. | ALA892798 | F | Antiviral activity against HAV in Vero cells assessed as plaque infectivity reduction at 20 ug/ml | Hepatovirus A | 10 | ALA1147850 | organism-based format | Scientific Literature | |
| 3. | ALA997849 | F | Antiviral activity against HAV 10 ug/10'5 cells by plaque infectivity assay | Hepatovirus A | 2 | ALA1155891 | organism-based format | Scientific Literature | |
| 4. | ALA997850 | F | Antiviral activity against HAV 10 ug/10'5 cells by plaque infectivity assay | Hepatovirus A | 2 | ALA1155891 | organism-based format | Scientific Literature | |
| 5. | ALA974132 | F | Antiviral activity against HAV cytHB1.1 in FRhK4 cells assessed as effect on cytopathogenic effect at 0.038 ug/mL after 21 days by immunofluorescence analysis | Hepatovirus A | 1 | ALA1142632 | organism-based format | Scientific Literature | |
| 6. | ALA974133 | F | Antiviral activity against HAV 7 in FRhK4 cells assessed as effect on cytopathogenic effect at 0.038 ug/mL after 21 days by immunofluorescence analysis | Hepatovirus A | 1 | ALA1142632 | organism-based format | Scientific Literature | |
| 7. | ALA1059056 | F | Antiviral activity against HAV MBB in human HepG2 cells assessed as reduction in viral titer at 10 ug/ml by plaque reduction assay | Human hepatitis A virus Hu/Northern Africa/MBB/1978 | 18 | ALA1153617 | organism-based format | Scientific Literature | |
| 8. | ALA1059057 | F | Antiviral activity against HAV MBB in human HepG2 cells assessed as reduction in viral titer at 20 ug/ml by plaque reduction assay | Human hepatitis A virus Hu/Northern Africa/MBB/1978 | 18 | ALA1153617 | organism-based format | Scientific Literature | |
| 9. | ALA1050715 | F | Antiviral activity against Hepatitis A virus infected african green monkey Vero cells at 10'-4 dilution of 5 mg/ml by plaque formation assay | Hepatovirus A | 5 | ALA1155362 | organism-based format | Scientific Literature | |
| 10. | ALA1050718 | F | Antiviral activity against HAV infected african green monkey Vero cells at 10'-3 dilution of 5 mg/ml by plaque formation assay | Hepatovirus A | 2 | ALA1155362 | organism-based format | Scientific Literature | |
| 11. | ALA1050721 | F | Antiviral activity against HAV infected african green monkey Vero cells at 10'-2 dilution of 5 mg/ml by plaque formation assay | Hepatovirus A | 2 | ALA1155362 | organism-based format | Scientific Literature | |
| 12. | ALA3055732 | F | Antiviral activity against Hepatitis A virus infected Vero cells assessed as reduction in viral plaque at 20 ug/ml after overnight incubation by crystal violet staining | Hepatovirus A | 8 | ALA3046360 | organism-based format | Scientific Literature | |
| 13. | ALA3055733 | F | Antiviral activity against Hepatitis A virus infected Vero cells assessed as reduction in viral plaque at 10 ug/ml after overnight incubation by crystal violet staining | Hepatovirus A | 8 | ALA3046360 | organism-based format | Scientific Literature | |
| 14. | ALA4342844 | F | Antiviral activity against Hepatitis A virus infected in HepG2 cells assessed as virus inhibition at 40 ug/L incubated overnight with virus followed by inoculation and measured after 1 hr by crystal violet staining based plaque reduction assay | Hepatovirus A | 5 | ALA4342407 | organism-based format | Scientific Literature | |
| 15. | ALA4391899 | F | Antiviral activity against Hepatitis A virus infected in rhesus monkey FRhK4 cells assessed as reduction in virus-induced cytopathic effect incubated for 72 hrs by MTT assay | Hepatovirus A | 24 | ALA4390665 | organism-based format | Scientific Literature | |
| 16. | ALA4391901 | F | Antiviral activity against Hepatitis A virus infected in rhesus monkey FRhK4 cells assessed as inhibition in viral adsorption using cells pre-incubated with compound for 24 hrs before viral infection for 1 hr by MTT assay | Hepatovirus A | 24 | ALA4390665 | organism-based format | Scientific Literature | |
| 17. | ALA4391902 | F | Antiviral activity against Hepatitis A virus infected in rhesus monkey FRhK4 cells assessed as inhibition in viral replication using cells pre-infected with virus before compound exposure for 72 hrs by MTT assay | Hepatovirus A | 24 | ALA4390665 | organism-based format | Scientific Literature | |
| 18. | ALA5115842 | F | Antiviral activity against hepatitis A virus genotype 1b infected in human Huh-7.5.1 cells assessed as reduction in virus production at 10 uM incubated for 72 hrs by Nano-Glo luciferase assay | Hepatovirus A | 42 | ALA5113410 | organism-based format | Scientific Literature | |
| 19. | ALA5115844 | F | Antiviral activity against hepatitis A virus genotype 1b infected in human Huh-7.5.1 cells assessed as reduction in virus production incubated for 72 hrs by Nano-Glo luciferase assay | Hepatovirus A | 4 | ALA5113410 | organism-based format | Scientific Literature | |
| 20. | ALA5115848 | F | Antiviral activity against hepatitis A virus HM175/18f infected in human Huh-7.5.1 cells assessed as reduction in HM175 production at 2 to 50 uM incubated for 72 hrs by RT-qPCR method | Hepatovirus A | 4 | ALA5113410 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!